Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Fengchao, Xu"'
Autor:
Xixi Fan, Fei Wang, Hongxiao Song, Fengchao Xu, Xiaolu Li, Qi Wei, Bingxin Lei, Zhongnan Wang, Yue Wang, Guangyun Tan
Publikováno v:
Journal of Traditional and Complementary Medicine, Vol 13, Iss 6, Pp 561-567 (2023)
Objective: Baicalin, which is a key bioactive constituent obtained from Scutellaria baicalensis, has been utilized in traditional Chinese medicine for many centuries. Although it has been reported that Baicalin (BA) can inhibit the replication of the
Externí odkaz:
https://doaj.org/article/6bb283d1fc244c098bb52bca2a608d9a
Autor:
Hongxiao Song, Qingfei Xiao, Fengchao Xu, Qi Wei, Fei Wang, Guangyun Tan, Rongman Jia, Xiuyuan Hao
Publikováno v:
Chinese Medical Journal, Vol 136, Iss 7, Pp 799-806 (2023)
Abstract. Background:. The hepatitis B virus (HBV) vaccine has been efficiently used for decades. However, hepatocellular carcinoma caused by HBV is still prevalent globally. We previously reported that interferon (IFN)-induced tripartite motif-conta
Externí odkaz:
https://doaj.org/article/958eb50302864862aba5cd3e8d8d1b8d
Publikováno v:
Frontiers in Microbiology, Vol 14 (2023)
Hepatitis B, a global health concern caused by the hepatitis B virus (HBV), infects nearly 2 billion individuals worldwide, as reported by the World Health Organization (WHO). HBV, a hepatotropic DNA virus, predominantly targets and replicates within
Externí odkaz:
https://doaj.org/article/d7591a6715244a10b4ef447c2db73ea5
Autor:
Xiaoli Pang, Hongxiao Song, Xiaolu Li, Fengchao Xu, Bingxun Lei, Fei Wang, Jing Xu, Lingli Qi, Libo Wang, Guangyun Tan
Publikováno v:
Journal of Translational Medicine, Vol 21, Iss 1, Pp 1-11 (2023)
Abstract Background Ulcerative colitis (UC) is a form of chronic inflammatory bowel disease of nonspecific origin. This study used an RNA-Sequencing (RNA-Seq) approach to evaluate the transcriptomic landscape of a well-stratified treatment-naïve ped
Externí odkaz:
https://doaj.org/article/889ac090a9414d54ac2efbd9098f56b2
Publikováno v:
Frontiers in Microbiology, Vol 13 (2022)
Hepatitis B virus (HBV) infection in humans and its associated diseases are long-standing problems. HBV can produce a large number of non-self-molecules during its life cycle, which acts as targets for innate immune recognition and initiation. Among
Externí odkaz:
https://doaj.org/article/fc4e76f7f14947e691514b5c94f8a239
Autor:
Qi Wei, Hongxiao Song, Yanli Gao, Fengchao Xu, Qingfei Xiao, Fei Wang, Bingxin Lei, Junqi Niu, Pujun Gao, Haichun Ma, Guangyun Tan
Publikováno v:
mBio, Vol 13, Iss 3 (2022)
ABSTRACT Hepatitis B virus (HBV)‐related diseases are among the major diseases that affect millions of people worldwide. These diseases are difficult to eradicate and thus pose a serious global health challenge. There is an urgent need to understan
Externí odkaz:
https://doaj.org/article/404ec2c2122e42459aba340fd805ee83
Autor:
Hongxiao Song, Fengchao Xu, Xiaoli Pang, Qingfei Xiao, Qi Wei, Bingxin Lei, Xiaolu Li, Xixi Fan, Guangyun Tan
Publikováno v:
Frontiers in Microbiology, Vol 12 (2021)
Owing to its broad-spectrum antivirus activities, interferon (IFN) is an important alternative agent for use in the treatment of hepatitis B virus (HBV)-infected patients; however, the mechanism involved in the inhibition of HBV infection and replica
Externí odkaz:
https://doaj.org/article/3fb0854f30c94ed390a63715bbe2d51a
Autor:
Guangyun Tan, Zhaohong Yi, Hongxiao Song, Fengchao Xu, Feng Li, Roghiyh Aliyari, Hong Zhang, Peishuang Du, Yanhua Ding, Junqi Niu, Xiaosong Wang, Lishan Su, F. Xiao-Feng Qin, Genhong Cheng
Publikováno v:
Cell Reports, Vol 29, Iss 11, Pp 3551-3563.e3 (2019)
Summary: To understand the molecular mechanisms that mediate the anti-hepatitis B virus (HBV) effect of interferon (IFN) therapy, we conduct high-throughput bimolecular fluorescence complementation screening to identify potential physical interaction
Externí odkaz:
https://doaj.org/article/695f17c007fb4daaa080546f55b0cc3a
Publikováno v:
Frontiers in Microbiology, Vol 10 (2019)
Therapeutic administration of type I IFN (IFN-I) is a common treatment option for individuals suffering from hepatitis B virus (HBV) infection. IFN-I therapy, however, has a relatively low response rate in HBV-infected patients and can induce serious
Externí odkaz:
https://doaj.org/article/f85355194e3b4a378b0fc55ff915c45b
Autor:
Guangyun Tan, Fengchao Xu, Hongxiao Song, Ye Yuan, Qingfei Xiao, Feng Ma, F. Xiao-Feng Qin, Genhong Cheng
Publikováno v:
Frontiers in Immunology, Vol 9 (2018)
Hepatitis B virus (HBV) remains a major cause of hepatic disease that threatens human health worldwide. Type I IFN (IFN-I) therapy is an important therapeutic option for HBV patients. The antiviral effect of IFN is mainly mediated via upregulation of
Externí odkaz:
https://doaj.org/article/0044c77455b24b3990800a0cedf7f692